Quantum Biopharma Ltd. (CVE:QNT – Get Free Report) Senior Officer Nathan Patrick Coyle sold 3,000 shares of the firm’s stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of C$20.16, for a total value of C$60,480.00.
Quantum Biopharma Stock Performance
Featured Articles
- Five stocks we like better than Quantum Biopharma
- Best Aerospace Stocks Investing
- Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones
- How to Start Investing in Real Estate
- MarketBeat Week in Review – 06/09 – 06/13
- 10 Best Airline Stocks to Buy
- IBM Up 10 Days in a Row: What’s Driving the Winning Streak?
Receive News & Ratings for Quantum Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
